Monographie - Diamorphine hydrochloride

Última actualización :
19/11/2024

Diamorphine hydrochloride

Factores que influyen sobre la estabilidad

Estructura química

Nombre comercial

Los nombres comerciales son orientativos y los excipientes de la formulación pueden ser distintos dependiendo del país y del laboratorio fabricante.

Diamorphine hydrochloride for injection	Gran Bretaña
Diaphin	Suiza

Bibliografía : Diamorphine hydrochloride

	Tipo	Publicación
339	periódico	Kleinberg ML, Duafala ME, Nacov C, Flora KP, Hines J, Davis K, McDaniel A, Scott D. Stability of heroin hydrochloride in infusion devices and containers for intravenous administration. Am J Hosp Pharm 1990 ; 47: 377-381.
484	periódico	Northcott M, Allsopp MA, Powell H, Sewell GJ. The stability of carboplatin, diamorphine, 5-fluorouracil and mitozantrone infusions in an ambulatory pump under storage and prolonged “in use” conditions. J Clin Pharm Ther 1991 ; 16: 123-129.
506	periódico	Omar OA, Hoskin PJ, Johnston A, Hanks W, Turner P. Diamorphine stability in aqueous solution for subcutaneous infusion. J Pharm Pharmacol 1989 ; 41: 275-277.
512	periódico	Barnes AR, Nash S. Stability of bupivacaine hydrochloride with diamorphine hydrochloride in an epidural infusion. Pharm World Sci 1995 ; 17: 87-92.
779	periódico	Collins AJ, Abethell JA, Holmes SG, Rain R. Stability of diamorphine hydrochloride with haloperidol in prefilled syringes for continuous subcutaneous administration. J Pharm Pharmacol 1986 ; 38: 51P.
788	periódico	Regnard CFB, Mannix K. Subcutaneous drug compatibility in palliative care. Lancet 1989 ; 2 (8670): 1044-1045.
1230	periódico	Regnard C, Pashley S, Westrope F. Anti-emetic / diamorphine mixture compatibility in infusion pumps. Br J Pharm Pract 1986 ; 8: 218-220.
1232	periódico	Beatson C, Taylor A. A physical compatibility study of furosemide & flucloxacillin injections. Br J Pharm Pract 1987 ; 9: 223-226, 236.
1288	periódico	Allwood MC, Brown PW, Lee M. Stability of injections containing diamorphine and midazolam in plastic syringes. Int J Pharm Pract 1994 ; 3: 57-59.
1292	periódico	Grassby PF, Roberts DE. Stability of epidural opiate solutions in 0.9 per cent sodium chloride infusion bags. Int J Pharm Pract 1995 ; 3: 174-177.
1385	periódico	Kirk B, Hain WR. Diamorphine injection BP incompatibility. Pharm J 1985 ; 235: 171.
1388	periódico	Page J, Hudson S. Diamorphine hydrochloride compatibility with saline. Pharm J 1982 ; 228: 238-239.
1886	periódico	Allwood MC. The stability of diamorphine alone and in combinaison with antiemetics in plastic syringes. Palliative Med 1991 ; 5: 330-333.
2051	periódico	Sanchez del Aguila MJ, Jones MF, Vohra A. Premixed solutions of diamorphine in ropivacaine for epidural anaesthesia: a study on long-term stability. Br J Anaesth 2003 ; 90: 179-182.
2307	periódico	Kreeger L, Cowin P, Noble-Gresty J, Naysmith A. Epidural diamorphine and bupivacaine stability study. Palliative Med 1995 ; 9, 4: 315-318.
2308	periódico	Hudson S.J, Jones M.F, Nolan S, Ellis H, Duncombe R, Alexander-Williams J.M. Stability of premixed syringes of diamorphine and hyperbaric bupivacaine. Int J Obstet Anesth 2005 ; 14, 4: 284-287.
2404	periódico	Fielding H, Kyaterekera , Skellern GG, Tettey JN, McDade JR, ZMsuya Z, Watson DG, Urie J. The compatibility and stability of octreotide acetate in the presence of diamorphine hydrochloride in polypropylene syringes Palliative Med 2000 ; 14: 205-208.
3184	Laboratorio	Hyaluronidase (Hyalase®) - Summary of Product characteristics. CP Pharmaceuticals 2005
3504	Laboratorio	Parecoxib (Dynastat®) - Summary of Product Characteristics Pfizer 2012

Mentions Légales